InnoCan Pharma Corp logo

InnoCan Pharma Corp

XCNQ:INNO (Canada)   Ordinary Shares
C$ 0.31 (-3.13%) Mar 28
At Loss
P/B:
12.73
Market Cap:
C$ 85.55M ($ 63.18M)
Enterprise V:
C$ 80.10M ($ 59.16M)
Volume:
104.50K
Avg Vol (2M):
62.36K
Also Trade In:
Volume:
104.50K
At Loss
Avg Vol (2M):
62.36K

Business Description

Description
InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 247.5
Equity-to-Asset 0.63
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.89
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 59.4
9-Day RSI 56.06
14-Day RSI 53.66
6-1 Month Momentum % 6.56
12-1 Month Momentum % 35.42

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.86
Quick Ratio 2.15
Cash Ratio 1.71
Days Inventory 428.01
Days Sales Outstanding 0.92
Days Payable 68.3

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.2
Shareholder Yield % -1.72

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 88.83
Operating Margin % -43.88
Net Margin % -51.03
FCF Margin % -40.65
ROE % -88.24
ROA % -73.32
ROIC % -245.53
ROC (Joel Greenblatt) % -557.07
ROCE % -81.61

Financials

XCNQ:INNO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

InnoCan Pharma Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 13.349
EPS (TTM) (C$) -0.026
Beta 0.09
Volatility % 68.91
14-Day RSI 53.66
14-Day ATR (C$) 0.015838
20-Day SMA (C$) 0.30025
12-1 Month Momentum % 35.42
52-Week Range (C$) 0.18 - 0.52
Shares Outstanding (Mil) 275.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

InnoCan Pharma Corp Filings

Filing Date Document Date Form
No Filing Data

InnoCan Pharma Corp Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

InnoCan Pharma Corp Frequently Asked Questions

What is InnoCan Pharma Corp(XCNQ:INNO)'s stock price today?
The current price of XCNQ:INNO is C$0.31. The 52 week high of XCNQ:INNO is C$0.52 and 52 week low is C$0.18.
When is next earnings date of InnoCan Pharma Corp(XCNQ:INNO)?
The next earnings date of InnoCan Pharma Corp(XCNQ:INNO) is .
Does InnoCan Pharma Corp(XCNQ:INNO) pay dividends? If so, how much?
InnoCan Pharma Corp(XCNQ:INNO) does not pay dividend.

Press Release

Subject Date
No Press Release